Jump to content

Galantamine: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
Auto-created stub
 
Expand stub to full MedTemplate parameter set
Line 1: Line 1:
{{MedTemplate
{{MedTemplate
| generic           = Galantamine
| generic           = Galantamine
| brand             = Razadyne
| brand             = Razadyne
| classes           = Anti-dementia, AChE inhibitor
| structure          =
| mechanism         = Acetylcholinesterase inhibitor; nicotinic ACh receptor modulator
| classes           = Anti-dementia, AChE inhibitor
| mechanism         = Acetylcholinesterase inhibitor; nicotinic ACh receptor modulator
| uses              =
| starting_dose      =
| preparations      =
| routes            =
| onset              =
| duration          =
| halflife          =
| bioavailability    =
| pregnancy          =
| legal              =
| intro              =
| pharmacokinetics  =
| pharmacodynamics  =
| indications        =
| dosing            =
| effects            =
| contraindications  =
| interactions      =
| pregnancy_details  =
| monitoring        =
| counseling        =
| anecdotes          =
| seealso            =
| references        =
}}
}}
[[Category:Anti-dementia]]
[[Category:Anti-dementia]]



Revision as of 01:00, 13 May 2026

Anti-dementia, AChE inhibitor
Galantamine
Razadyne

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Classes
Anti-dementia, AChE inhibitor
Common uses
Pharmacy
Pharmacology
Purported mechanism
Acetylcholinesterase inhibitor; nicotinic ACh receptor modulator